Post by : Badri Ariffin

M42 has shared exciting findings from a national initiative in collaboration with the Department of Health – Abu Dhabi, revealing the role of genomics in the early identification and prevention of inherited eye diseases.

This comprehensive study pinpointed approximately 100 genetic factors linked to inherited vision loss among Emiratis, marking a pivotal moment in understanding genetic vulnerabilities related to eye health and enabling more precise early interventions.

Researchers delved into genomic data from over 500,000 Emirati citizens, all part of the Emirati Genome Programme, which is overseen by the Emirates Genome Council and supported by various national partners. This rich database aims to bolster preventive healthcare initiatives across the population.

This advancement underscores Abu Dhabi's commitment to a healthcare paradigm that prioritizes prevention and early diagnosis rather than solely treating established illnesses. Researchers effectively combined genetic insights with anonymized health records via Malaffi, transforming scientific data into actionable insights for healthcare professionals and planners.

This methodology equips physicians to flag individuals at elevated risk of disease prior to the emergence of symptoms and enhances early surveillance, genetic counseling, and bespoke treatment strategies.

Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, remarked that this study reflects the emirate's robust dedication to leveraging advanced scientific research and data for healthcare enhancement. She emphasized that genomics is pivotal for early detection, preventive measures, and effective health policies to safeguards public health over time.

Dimitris Moulavasilis, Group CEO of M42, affirmed that the research illustrates how fusing genomics with practical health data can yield superior preventive measures and tailored healthcare solutions.

The study brought to light specific genes such as ABCA4, linked to inherited retinal diseases like Stargardt disease—a rare condition resulting in progressive central vision loss, often commencing in youth.

Additionally, researchers identified a rare yet treatable genetic condition that can lead to early vision impairments. This emphasizes the capability of extensive genomic studies to enable prompt diagnosis and tailored treatments. Notably, the research reaffirmed that a larger presence of a genetic variant does not necessarily correlate with an increased disease risk.

The Emirati Genome Programme stands as one of the world's largest national genome sequencing initiatives, having sequenced over 850,000 genomes to date. This research further enhances Abu Dhabi's status as a pioneering hub in health innovation and its dedication to improving quality of life through cutting-edge scientific advancements.

#Global News #UAE News #Abu Dhabi News #Abu Dhabi